Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10900034 Guide RNA with chemical modifications

Patent 10900034 was granted and assigned to Agilent Technologies on January, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Agilent Technologies

0

Current Assignee

Agilent Technologies

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Robert Kaiser0

Daniel E. Ryan0

Douglas J. Dellinger0

Jeffrey R. Sampson0

Joel Myerson0

Date of Patent

January 26, 2021

0

Patent Application Number

147572040

Date Filed

December 3, 2015

0

Patent Citations Received

US Patent 11492646 Nuclease-mediated genome editing of primary cells

0

US Patent 11634732 Pharmaceutical compositions comprising gene-corrected primary cells

0

US Patent 11851652 Compositions comprising chemically modified guide RNAs for CRISPR/Cas-mediated editing of HBB

0

US Patent 11884915 Guide RNAs with chemical modification for prime editing

0

Patent Primary Examiner

Channing S Mahatan

0

Patent abstract

The present invention relates to modified guide RNAs and their use in clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-associated (Cas) systems.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10900034 Guide RNA with chemical modifications

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool